Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catumaxomab in Gastric Peritoneal Carcinomatosis
NCT01784900Phase 2Terminated
- Sponsor
- Gustave Roussy
- Start
- Nov 2012
- Primary completion
- Jan 2016
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of catumaxomab in peritoneal carcinomatosis (PC), sponsored by Gustave Roussy. Started Nov 2012; status: terminated.
02
Drugs
catumaxomab
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT01784900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784900.